CLB was recommended by Cabot Global Energy Investor at $116.26 in Investment Digest issue 699, dated July 20, 2011.
“Core Laboratories N.V. (CLB) fell below its stop limits on Friday, at $134.09, and should now be sold. Crude oil continues to falter, driven by a weakening euro, so we won’t fight the trend but look to re-buy at a lower re-entry point. SELL.”
- Lou Gagliardi, Cabot Global Energy Investor, May 21, 2012